Omalizumab as Third-Line Therapy for Urticaria During Pregnancy

Omalizumab as Third-Line Therapy for Urticaria During Pregnancy

Author Ensina, L. F. Autor UNIFESP Google Scholar
Cusato-Ensina, A. P. Google Scholar
Camelo-Nunes, I. C. Autor UNIFESP Google Scholar
Sole, D. Autor UNIFESP Google Scholar
Keywords Urticaria
Omalizumab
Angioedema
Therapeutics
xmlui.dri2xhtml.METS-1.0.item-coverage Barcelona
Language English
Date 2017
Published in Journal Of Investigational Allergology And Clinical Immunology. Barcelona, v. 27, n. 5, p. 326-327, 2017.
ISSN 1018-9068 (Sherpa/Romeo, impact factor)
Publisher Esmon Publicidad S A, Dept Allergy
Extent 326-327
Origin http://dx.doi.org/10.18176/jiaci.0179
Access rights Closed access
Type Editorial
Web of Science ID WOS:000416501500011
URI https://repositorio.unifesp.br/handle/11600/55425

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account